Pharmaceuticals, Biotechnology and Life Sciences
NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) today announced the United States (U.S.) Food and Drug Administration (FDA) has approved NYVEPRIA™…
NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) today announced the United States (U.S.) Food and Drug Administration (FDA) has approved NYVEPRIA™…
Mr. Wilson is an experienced intellectual property attorney with deep expertise in drug development WALTHAM, Mass.–(BUSINESS WIRE)–Dyne Therapeutics, a biotechnology…
Mr. Wilson is an experienced intellectual property attorney with deep expertise in drug development WALTHAM, Mass.–(BUSINESS WIRE)–Dyne Therapeutics, a biotechnology…
Mr. Wilson is an experienced intellectual property attorney with deep expertise in drug development WALTHAM, Mass.–(BUSINESS WIRE)–Dyne Therapeutics, a biotechnology…
Mr. Wilson is an experienced intellectual property attorney with deep expertise in drug development WALTHAM, Mass.–(BUSINESS WIRE)–Dyne Therapeutics, a biotechnology…
Mr. Wilson is an experienced intellectual property attorney with deep expertise in drug development WALTHAM, Mass.–(BUSINESS WIRE)–Dyne Therapeutics, a biotechnology…
CARLSBAD, Calif.–(BUSINESS WIRE)–$LCTX #AMD—Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies…
CARLSBAD, Calif.–(BUSINESS WIRE)–$LCTX #AMD—Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies…
CARLSBAD, Calif.–(BUSINESS WIRE)–$LCTX #AMD—Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies…